Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Jenneke Leentjens, Thijs F. van Haaps, Pieter Wessels, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 7, pp. e524-e533
Open Access | Times Cited: 219

Showing 51-75 of 219 citing articles:

Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention
Nikola Gligorijević, Mirjana Radomirović, Olgica Nedić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12385-12385
Open Access | Times Cited: 24
Plasma P‐selectin is an early marker of thromboembolism in COVID‐19
Bánk G. Fenyves, Arnav Mehta, Kyle R. Kays, et al.
American Journal of Hematology (2021) Vol. 96, Iss. 12
Open Access | Times Cited: 23
Sex‐specific aspects of venous thromboembolism: What is new and what is next?
Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Suzanne C. Cannegieter
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 4, pp. e12722-e12722
Open Access | Times Cited: 16
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W. Eikelboom, Sanjit S. Jolly, Emilie P. Belley‐Côté, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1160-1168
Open Access | Times Cited: 16
Imaging Severity COVID-19 Assessment in Vaccinated and Unvaccinated Patients: Comparison of the Different Variants in a High Volume Italian Reference Center
Vincenza Granata, Roberta Fusco, Alberta Villanacci, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 955-955
Open Access | Times Cited: 15
Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S
Bas de Laat, Hendrik Stragier, Romy de Laat‐Kremers, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 15
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years
John G. Rizk, Aashish Gupta, Jose G. Lazo, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 01, pp. 062-072
Closed Access | Times Cited: 14
Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19
Michael Hultström, Robert Frithiof, Jonathan Grip, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 861-864
Open Access | Times Cited: 13
Immune response induced by novel coronavirus infection
Ying Sun, Yawen Zou, Haiyu Wang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 13
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C
Anna Schmitz, Kelly E. Wood, Elliot Burghardt, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 5, pp. e12780-e12780
Open Access | Times Cited: 12
COVID-19 and the Response to Antiplatelet Therapy
Tomáš Bolek, Matej Samoš, Jakub Jurica, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2038-2038
Open Access | Times Cited: 7
Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study
Yu Shionoya, Toshibumi Taniguchi, Hajime Kasai, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0256977-e0256977
Open Access | Times Cited: 16
Post-COVID condition: dispensation of drugs and diagnostic tests as proxies of healthcare impact
Alessandro Nobili, Barbara D’Avanzo, Mauro Tettamanti, et al.
Internal and Emergency Medicine (2023) Vol. 18, Iss. 3, pp. 801-809
Open Access | Times Cited: 6
Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D
Hana Fakhoury, Peter R. Kvietys, Ismail Shakir, et al.
Nutrients (2021) Vol. 13, Iss. 7, pp. 2216-2216
Open Access | Times Cited: 15
Fibrin monomers evaluation during hospitalization for COVID-19 is a predictive marker of in-hospital mortality
David M. Smadja, Nicolas Gendron, Aurélien Philippe, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Platelet Surface Protein Expression and Reactivity upon TRAP Stimulation after BNT162b2 Vaccination
Melissa Klug, Olga Lazareva, Kilian Kirmes, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 10, pp. 1706-1711
Open Access | Times Cited: 13
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study
Bingwen Eugene Fan, Kollengode Ramanathan, Christina Lai Lin Sum, et al.
Journal of Thrombosis and Thrombolysis (2021) Vol. 53, Iss. 3, pp. 646-662
Open Access | Times Cited: 13
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19
Jun Wang, Prasanti Kotagiri, Paul Lyons, et al.
iScience (2022) Vol. 25, Iss. 3, pp. 103971-103971
Open Access | Times Cited: 9
Venous thromboembolism in Black COVID-19 patients in a minority context compared to White, Asian and other racialized patients: A systematic review and meta-analysis
Jude Mary Cénat, Élisabeth Dromer, Seyed Mohammad Mahdi Moshirian Farahi, et al.
Thrombosis Research (2024) Vol. 238, pp. 197-205
Closed Access | Times Cited: 1
Modulatory role of Faecalibacterium on insulin resistance and coagulation in patients with post-viral long haulers depending on adiposity
Amanda Cuevas‐Sierra, Lourdes Chero‐Sandoval, Andrea Higuera‐Gómez, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110450-110450
Open Access | Times Cited: 1
POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes
Tobias Tritschler, Grégoire Le Gal, Shari B. Brosnahan, et al.
CHEST Journal (2022) Vol. 161, Iss. 6, pp. 1446-1448
Open Access | Times Cited: 8
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis
Małgorzata Dybowska, Dorota Wyrostkiewicz, Lucyna Opoka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10372-10372
Open Access | Times Cited: 8
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?
Goran Rondović, Dragan Djordjević, Ivo Udovičić, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2620-2620
Open Access | Times Cited: 8
Incidence of lower limb deep vein thrombosis in patients with COVID-19 pneumonia through different waves of SARS-CoV-2 pandemic: A multicenter prospective study
Filippo Pieralli, Fulvio Pomero, Lorenzo Corbo, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0280247-e0280247
Open Access | Times Cited: 4
Cancer, more than a “COVID-19 co-morbidity”
Chinmay Jani, Robert T. Schooley, Rana R. McKay, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4

Scroll to top